Peptide questions · Pancragen
Pancragen side effects: what studies and users report
Reviewed Evidence: EmergingPublished by PepVault
The library lists one common side effect for pancragen, injection-site redness or itch, and a safety note; its evidence in people comes from small studies without a control group and from clinical use.
Its safety note opens: No study has looked at the safety of pancragen on its own, and its long-term effects are unknown.
What is commonly reported with pancragen
- Injection-site redness or itch
Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.
| Effect | Also listed for (of 18) |
|---|---|
| Injection-site redness or itch | 2: Bronchogen, Cardiogen |

Which pancragen side effects the longevity group shares
Across the 19 longevity compounds in the library, the effects listed most often are injection site reaction (5 of 19), injection-site discomfort (3 of 19), injection-site redness or itch (3 of 19) and mild headache (3 of 19). Every effect on pancragen’s list also appears for at least one other longevity compound, so nothing on it is pancragen’s own.
What the pancragen safety notes say
The library’s safety note
No study has looked at the safety of Pancragen on its own, and its long-term effects are unknown. It lowered blood sugar in rats, monkeys and people with type 2 diabetes, so anyone on insulin or other glucose-lowering medicine, or prone to low blood sugar, has a reason to talk with their clinician first. Discuss with your clinician before use, particularly during pregnancy or breastfeeding.
The library’s interaction note
No interaction studies exist. Its glucose-lowering effect in studies makes insulin, sulfonylureas such as glimepiride, and other diabetes medicines the ones to raise with your clinician.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Where the pancragen reports come from
The library rates the evidence on pancragen as emerging: mostly preclinical, with limited human data.
Of the library’s 5 research notes on pancragen, 2 rest on clinical data, 1 on animal studies and 2 on community reports.
Our 1 study page on pancragen: 1 clinical trial.
So the effects listed for pancragen come from uncontrolled studies and use in people, not from placebo-controlled trials.
Questions people ask
What are the side effects of pancragen?
The library lists one common side effect for pancragen, injection-site redness or itch, and a safety note; its evidence in people comes from small studies without a control group and from clinical use.
Do pancragen’s side effects come from human studies?
The library rates the evidence on pancragen as emerging, and its evidence in people comes from small studies without a control group and from clinical use.
Which pancragen side effects are its own?
None: each effect the library lists for pancragen is listed for at least one other longevity compound too.
Does pancragen interact with other medicines?
The library’s interaction note on pancragen begins: No interaction studies exist.